IP Library Granted Patent US 9,408,902
Granted Patent B2
US 9,408,902 · App. 12/108,458 · Granted Aug 9, 2016

Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture

Inventors: Samuel Bogoch (New York, NY); Elenore S. Bogoch (New York, NY); Samuel Winston Bogoch (Oakland, CA); Anne Elenore Borsanyi (Brookline, MA)
A61K39/125A61K39/12C07K14/005C07K14/72A61K39/00A61K2039/542A61K2039/552C12N2710/18022C12N2760/16022C12N2770/24122C12N2770/32022C12N2770/32034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,902
App. No.
12/108,458
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention provides isolated or synthesized peptides of about 7 to about 50 amino acids identified in the genome of pathogens in invertebrates in aquaculture for prevention and treatment of outbreaks of these pathogens in aquaculture and methods of preventing and treating pathogenic outbreaks using the identified peptides.

Claims (17)

1. A method of increasing survival in shrimp exposed to taura syndrome virus comprising administering to at least one shrimp a substance comprising a mixture of isolated or synthetic peptides, wherein each peptide of the mixture consists of 7 to 50 amino acids and wherein the mixture includes peptides comprising at least each of the following sequences of KVGSRRYKSH (SEQ ID NO: 1), HFATKCFGEVPKK (SEQ ID NO: 2), KAENEFWDGVKQSH (SEQ ID NO: 3), KGHRKVPCEQK (SEQ ID NO: 4), HRKVPCEQK (SEQ ID NO: 5), KVPCEQKIWLH (SEQ ID NO: 6), KIWLHQNPGK (SEQ ID NO: 7), HQNPGKTQQDMK (SEQ ID NO: 8), KGNTRVHVK (SEQ ID NO: 9), KEHVEKIVDK (SEQ ID NO: 10), and HVEKIVDKAK (SEQ ID NO: 11).

2. The method of claim 1 , wherein said isolated or synthetic peptides are synthetic.

3. The method of claim 1 , wherein said substance comprises a mixture consisting of the isolated or synthetic peptides KVGSRRYKSH (SEQ ID NO: 1), HFATKCFGEVPKK (SEQ ID NO: 2), KAENEFWDGVKQSH (SEQ ID NO: 3), KGHRKVPCEQK (SEQ ID NO: 4), HRKVPCEQK (SEQ ID NO: 5), KVPCEQKIWLH (SEQ ID NO: 6), KIWLHQNPGK (SEQ ID NO: 7), HQNPGKTQQDMK (SEQ ID NO: 8), KGNTRVHVK (SEQ ID NO: 9), KEHVEKIVDK (SEQ ID NO: 10), and HVEKIVDKAK (SEQ ID NO: 11).

4. The method of claim 1 , wherein said isolated or synthetic peptides consist of up to 15 amino acids.

5. The method of claim 1 , wherein said substance further comprises a pharmaceutically acceptable carrier.

6. The method of claim 1 , wherein said substance comprises feed.

7. The method of claim 6 , wherein said feed comprises a daily ration of feed for shrimp.

8. The method of claim 3 , wherein said substance comprises an equal mixture by weight of each of said isolated or synthetic peptides.

9. The method of claim 3 , wherein said substance is administered to shrimp at a dose of about 0.01 mg to about 2 mg per gram of body weight of each shrimp per day.

10. The method of claim 9 , wherein said dose is about 0.2 mg to 1.0 mg per gram of body weight of each shrimp per day.

11. The method of claim 10 , wherein said dose is about 0.5 mg per gram of body weight of each shrimp per day.

12. The method of claim 1 , wherein said substance is administered to shrimp as a prophylactic therapy prior to the onset of symptoms of a taura syndrome virus.

13. The method of claim 1 , wherein said substance is administered to shrimp as a therapy after the onset of symptoms of taura syndrome virus.

14. The method of claim 1 , wherein said substance is administered to shrimp as a prophylactic therapy at sub-therapeutic concentrations.

15. The method of claim 14 , wherein said substance is administered over substantially the entire life cycle of at least one shrimp.

16. The method of claim 1 , wherein said substance is administered orally, via submersion of the invertebrate in an aqueous medium containing said substance, or via injection.

17. The method of claim 1 , wherein said substance is administered orally.

Continuity (11)
Continuation In Part 11755597 · May 30, 2007
Continuation In Part 11923559 · Oct 24, 2007
Continuation In Part 12010027 · Jan 18, 2008
Provisional Application 60594743 · Aug 8, 2007
Provisional Application 60935499 · Aug 16, 2007
Provisional Application 60935816 · Aug 31, 2007
Provisional Application 60982338 · Oct 24, 2007
Provisional Application 60982333 · Oct 24, 2007
Provisional Application 60982336 · Oct 24, 2007
Provisional Application 60991676 · Nov 30, 2007
Related Publication 20090041795A1 · Feb 12, 2009